Transforming growth factor-β
(TGF-β) is a well-known
disease-related biomarker associated with fibrotic diseases, and initiation
and progression of cancer in many organs. Therefore, quantitative
and sensitive detection of TGF-β and similar biomarkers is crucial
for patient treatment in the early stages of diagnosis. In many studies,
the detection of TGF-β, an important profibrotic and cancer
promoting cytokine, has been generally conducted by fluorescence or
absorbance-based immunoassays. However, conventional methods for detecting
TGF-β have problems including use of time-consuming sample pretreatment
steps and multiple reagents for signal amplification and difficulty
in real-time detection from living cells. Herein, we present a plasmon-based
immunoassay for TGF-β using antibody-conjugated single gold
nanoparticles that act as optically excellent intracellular and extracellular
detection probes that do not require additional signal amplification.
To detect TGF-β sensitively and selectively, we exploited the
localized surface plasmon resonance (LSPR) property of antibody-conjugated
plasmonic gold nanoparticles at a single particle level. By measuring
the LSPR spectral shifts of the single plasmonic nanoprobes, TGF-β
can be detected down to the picomolar level, which is comparable with
the conventional methods but without significant interference from
other proteins. The optimized plasmonic nanoprobes were applied to
quantify and monitor the extracellular TGF-β level secreted
from the cells under stress conditions, such as cancer, and exposure
to toxic environments. Owing to the ease of cellular internalization
of the nanoprobes, we directly image and detect increases in intracellular
TGF-β levels in living cells under the given stress conditions
without cell lysis. We envision that this strategy of using individual
nanoparticles as sensors to monitor protein biomarkers in living cells
could be applied for various biological assays and diagnosis.